We are testing different doses of BI 764532 in patients with small cell lung cancer and other neuroendocrine tumors that are positive for DLL3. This study aims to find the most effective dose for these specific cancers.
Health conditions and diseases that the clinical trial is designed to study and treat.
Small Cell Lung Carcinoma (SCLC) is a fast-growing type of lung cancer that typically starts in the bronchi and is often associated with smoking. It can spread quickly and may cause symptoms like coughing, chest pain, and shortness of breath.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
